2026-10-14T11:20:09Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33948628 2026-09-21T04:22:50Z category_363 portal_316 item_type_3 month_year_09_2026

Table 1_Associations between obstructive sleep apnea and Alzheimer's disease-related biomarkers (amyloid-β and tau) in blood and cerebrospinal fluid: a systematic review and meta-analysis.docx Jing Wang (6206297) Ligeer Che (22518114) Rina Su (520454) Xianbin Wang (3336642) Neurology and Neuromuscular Diseases Alzheimer's disease blood biomarkers cerebrospinal fluid biomarkers meta-analysis obstructive sleep apnea systematic review Purpose<p>This study aimed to clarify the relationship between obstructive sleep apnea (OSA) and Alzheimer's disease (AD)-related biomarkers—specifically amyloid β (Aβ) and tau proteins—in blood and cerebrospinal fluid (CSF) through a systematic review and meta-analysis.</p>Methods<p>PubMed, Web of Science (WOS), Embase, and Cochrane Library were searched from database inception to December 30, 2024 (PROSPERO registration: CRD420251148709). Studies reporting blood or CSF levels of Aβ40, Aβ42, total Aβ (T-Aβ), total tau (T-tau), or phosphorylated tau (P-tau) in patients with OSA vs. non-OSA controls were included. A random-effects model was employed for all meta-analyses. The risk of bias was assessed using appropriate validated tools.</p>Results<p>Thirteen studies (seven blood, six CSF) were included. In blood, OSA patients showed significantly higher T-Aβ (SMD = 0.66, 95% CI [0.34, 0.97], I² = 0%, p < 0.01) and T-tau (SMD = 1.48, 95% CI [0.33, 2.62], I² = 93.6%, p = 0.011). No significant differences were found for blood Aβ40, Aβ42, Aβ42/Aβ40 ratio, or P-tau. In CSF, patients with OSA had significantly lower Aβ40 (SMD = −1.13, 95% CI [−1.65, −0.60], I² = 0%, p < 0.01) and Aβ42 (SMD = −1.23, 95% CI [−1.84, −0.63], I² = 77.3%, p < 0.01), but no differences in Aβ42/Aβ40 ratio, T-tau, or P-tau.</p>Limitations<p>High heterogeneity, pre-dominantly cross-sectional designs, low-to-very-low GRADE certainty for most outcomes, retrospective registration, and limited study numbers preclude causal inference and warrant cautious interpretation.</p>Conclusions<p>This exploratory meta-analysis revealed compartment-specific associations between certain AD-related biomarkers and OSA. However, given the low-to-very-low certainty of the available evidence and the substantial uncertainty reflected by prediction intervals that frequently crossed the null value, these findings should be regarded as hypothesis-generating rather than conclusive. Notably, the absence of consistent alterations in P-tau or the CSF Aβ42/Aβ40 ratio argues against a direct signature of established AD neuropathology. Future rigorously designed, large-scale prospective studies are warranted to determine whether these biomarker changes reflect early AD pathology or reversible physiological responses to OSA-related hypoxia and sleep fragmentation.</p><p>Systematic review registration:https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=1148709, identifier CRD420251148709.</p> 2026-09-21T04:22:50Z Dataset Dataset 10.3389/fneur.2026.1817426.s001 https://figshare.com/articles/dataset/Table_1_Associations_between_obstructive_sleep_apnea_and_Alzheimer_s_disease-related_biomarkers_amyloid-_and_tau_in_blood_and_cerebrospinal_fluid_a_systematic_review_and_meta-analysis_docx/33948628 CC BY 4.0